Hu et al., J Biol Chem 2006
(MAP Kinase Signaling System) :
MAPKAPK-2, Akt2, and ezrin phosphorylation were all attenuated by p38 MAPK inhibition but were unaffected by dominant negative ezrin expression
Gao et al., J Biol Chem 2009
(Esophageal Neoplasms...) :
Use of selective inhibitors revealed that VIL2 transactivation required the MEK1/2 signal transduction pathway but not JNK or p38 MAPK